- Home
- MLTX vs KSS Comparison
MLTX vs KSS Comparison
Compare MLTX & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | KSS |
|---|---|---|
| Founded | 2021 | 1962 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MLTX | KSS |
|---|---|---|
| Price | $19.48 | $18.71 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 12 | 15 |
| Target Price | ★ $27.50 | $15.31 |
| AVG Volume (30 Days) | 1.3M | ★ 4.4M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | N/A | ★ 142.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $8.88 |
| 52 Week High | $62.75 | $25.22 |
Technical Indicators
Market Signals| Indicator | MLTX | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 63.48 |
| Support Level | $15.54 | $14.64 |
| Resistance Level | $21.00 | $20.43 |
| Average True Range (ATR) | 1.10 | 1.06 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 36.62 | 81.52 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About KSS Kohl's Corporation
Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.